rss
J Clin Pathol 2001;54:187-190 doi:10.1136/jcp.54.3.187

Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?

  1. R J Lock,
  2. D J Unsworth
  1. Department of Immunology, Southmead Hospital, Bristol BS10 5NB, UK
  1. Dr Unsworth joeunsworth{at}hotmail.com
  • Accepted 21 August 2000

Abstract

Precipitating antibodies to extractable nuclear antigens are important in the diagnosis of connective tissue diseases. Disease associations are defined using gel based techniques. Alternative technologies have been introduced, including passive haemagglutination, enzyme linked immunosorbent assay, and western blotting. This leader contains a review of the literature on the clinical usefulness of these assays, together with knowledge gained from personal experience. Using the example of systemic lupus erythematosus, the sensitivity, specificity, and positive predictive value of the assays for disease is discussed, as is their differences in performance. The conclusion drawn is that disease specificity is method dependent. Validation and audit of performance of the method selected by the investigation laboratory is essential.

Footnotes

    Latest from JCP Education

    Latest from JCP Education

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
    View free sample issue >>

    Free archive
    The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs